George Carter

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Neha Korde, Mark Roschewski, Adriana Zingone et al. · JAMA Oncology · 2015 · 309 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Ion-assisted deposition of CN and SiCN films

Zhigang He, George Carter, John S. Colligon · Thin Solid Films · 1996 · 63 citations

Natural Sciences, Materials Engineering, Materials Science +12

trans-Activation and Repression Properties of the Novel Nonsteroid Glucocorticoid Receptor Ligand 2,5-Dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and Its Four Stereoisomers

Chun Wel Lin, Masaki Nakane, Mike Stashko et al. · Molecular Pharmacology · 2002 · 50 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

ABT-963 [2-(3,4-Difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2 H-pyridazin-3-one], A Highly Potent and Selective Disubstituted Pyridazinone Cyclooxgenase-2 Inhibitor

Richard R. Harris, Lawrence A. Black, Sekhar Surapaneni et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 45 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Phase II Clinical and Correlative Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRD-R) Induces High Rates Of MRD Negativity In Newly Diagnosed Multiple Myeloma (MM) Patients

Neha Korde, Adriana Zingone, Mary Kwok et al. · Blood · 2013 · 40 citations

Medicine, Hematology, Pharmacotherapy +16